Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma - Concepedia

Concepedia

Publication | Closed Access

Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma

159

Citations

29

References

2002

Year

Hans D. Menssen, A Sakalová, A Fontana, Z. Herrmann, C Boewer, Thierry Façon, Charles R.J. Singer, Liana Euller‐Ziegler, Marc Wetterwald, D Fière,

Journal of Clinical Oncology

Abstract

Monthly injections of ibandronate 2 mg IV neither reduced bone morbidity nor prolonged survival in the overall population of stage II/III multiple myeloma patients.

References

	Year	Citations

Page 1